Legislative Research: NY A08501 | 2023-2024 | General Assembly
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 General Assembly (Passed) | Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable... [A08501 2023 Detail][A08501 2023 Text][A08501 2023 Comments] | 2024-02-07 signed chap.28 |
| 2021-2022 General Assembly (Introduced - Dead) | Establishes the New York state masters-in-mental health incentive scholarship program for qualified persons at a New York state public institution of higher education who seeks a career as a mental health clinician; requires such person to enroll in ... [A08501 2021 Detail][A08501 2021 Text][A08501 2021 Comments] | 2022-01-05 referred to higher education |
| 2019-2020 General Assembly (Introduced - Dead) | Imposes term limits of no more than four four year terms for members of the legislature. [A08501 2019 Detail][A08501 2019 Text][A08501 2019 Comments] | 2020-02-14 opinion referred to judiciary |
| 2017-2018 General Assembly (Introduced - Dead) | Directs the commissioner of the division of homeland security and emergency services to work with other experts who maintain experience and knowledge in the area of cyber security to develop a cyber security action plan for New York state. [A08501 2017 Detail][A08501 2017 Text][A08501 2017 Comments] | 2018-02-02 print number 8501a |
| 2015-2016 General Assembly (Introduced - Dead) | Provides that no person shall manufacture, sell or expose for sale any product which shall be termed as a dietary supplement or nutritional supplement without branding or labeling such product with a statement that the product has or has not been tes... [A08501 2015 Detail][A08501 2015 Text][A08501 2015 Comments] | 2016-01-06 referred to agriculture |
| 2013-2014 General Assembly (Introduced - Dead) | Establishes as a distinct territory for purposes of rating private passenger nonbusiness automobile insurance policies, a certain city with a population between 19,040 and 25,000 which is geographically contiguous to a city with a population between ... [A08501 2013 Detail][A08501 2013 Text][A08501 2013 Comments] | 2014-01-17 referred to insurance |
| 2011-2012 General Assembly (Introduced - Dead) | Extends the provisions of rent control laws. [A08501 2011 Detail][A08501 2011 Text][A08501 2011 Comments] | 2011-06-20 substituted by s5831 |
| 2009-2010 General Assembly (Passed) | Enacts the NY government reorganization and citizen empowerment act: relates to the requirements for consolidation or dissolution of certain local government entities. [A08501 2009 Detail][A08501 2009 Text][A08501 2009 Comments] | 2009-06-24 signed chap.74 |
References Online
| Search Phrase | Web | News | Financial | Encylopedia | Biography |
|---|---|---|---|---|---|
| [New York A08501] | Google Web | Google News | |||
| [Assemblymember John McDonald NY] | Google Web | Google News | FollowTheMoney | Ballotpedia | VoteSmart |
Legislative Citation
APA
NY A08501 | 2023-2024 | General Assembly. (2024, February 07). LegiScan. Retrieved September 04, 2024, from https://legiscan.com/NY/bill/A08501/2023
MLA
"NY A08501 | 2023-2024 | General Assembly." LegiScan. LegiScan LLC, 07 Feb. 2024. Web. 04 Sep. 2024. <https://legiscan.com/NY/bill/A08501/2023>.
Chicago
"NY A08501 | 2023-2024 | General Assembly." February 07, 2024 LegiScan. Accessed September 04, 2024. https://legiscan.com/NY/bill/A08501/2023.
Turabian
LegiScan. NY A08501 | 2023-2024 | General Assembly. 07 February 2024. https://legiscan.com/NY/bill/A08501/2023 (accessed September 04, 2024).
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| S08038 | Same As | 2024-01-29 | Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent. | SUBSTITUTED BY A8501 |
